CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 31 entries

View as:

Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT04645953 Org: User:

Start: 02/05/21 End: 07/26/22 Due: 07/26/23

Staccato Loxapine Multidose PK

Phase: N/A Priority: Normal

NCT ID: NCT00555412 Org: User:

Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Staccato Loxapine in Agitated Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00628589 Org: User:

Start: 02/29/08 End: 05/31/08 Due: 05/31/09

Staccato Prochlorperazine in Migraine (Out Patient)

Phase: N/A Priority: Normal

NCT ID: NCT00422812 Org: User:

Start: 04/30/06 End: 01/31/07 Due: 01/31/08

Staccato Alprazolam in Panic Attack

Phase: N/A Priority: Normal

NCT ID: NCT00477451 Org: User:

Start: 05/31/07 End: 04/30/08 Due: 04/30/09

Staccato Loxapine Pulmonary Safety in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00789360 Org: User:

Start: 11/30/08 End: 04/30/09 Due: 04/30/10

Staccato Zaleplon Single Dose Pharmacokinetics

Phase: N/A Priority: Normal

NCT ID: NCT00620620 Org: User:

Start: 02/29/08 End: 03/31/08 Due: 03/31/09

ADASUVE-Lorazepam Drug-Drug Interaction

Phase: N/A Priority: Normal

NCT ID: NCT01877642 Org: User:

Start: 06/30/13 End: 07/31/13 Due: 07/31/14

Staccato Prochlorperazine Single Dose PK Study

Phase: N/A Priority: Normal

NCT ID: NCT00610727 Org: User:

Start: 08/31/04 End: 10/31/04 Due: 10/31/05

Staccato Loxapine PK in Smokers and Nonsmokers

Phase: N/A Priority: Normal

NCT ID: NCT00873769 Org: User:

Start: 04/30/09 End: 06/30/09 Due: 06/30/10

Staccato Loxapine in Migraine (in Clinic)

Phase: N/A Priority: Normal

NCT ID: NCT00489476 Org: User:

Start: 06/30/07 End: 12/31/07 Due: 12/31/08

Staccato Loxapine Thorough QT/QTc Study

Phase: N/A Priority: Normal

NCT ID: NCT00874237 Org: User:

Start: 04/30/09 End: 06/30/09 Due: 06/30/10

Staccato Alprazolam Abuse Liability

Phase: N/A Priority: Normal

NCT ID: NCT00603980 Org: User:

Start: 01/31/08 End: 01/31/09 Due: 01/31/10

ADASUVE 2-dose Thorough QT/QTc Study

Phase: N/A Priority: Normal

NCT ID: NCT01854710 Org: User:

Start: 05/31/13 End: 07/31/13 Due: 07/31/14

Staccato Loxapine Pulmonary Safety in Patients With COPD

Phase: N/A Priority: Normal

NCT ID: NCT00889837 Org: User:

Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Staccato Prochlorperazine Thorough QT/QTc

Phase: N/A Priority: Normal

NCT ID: NCT00543062 Org: User:

Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Staccato Alprazolam and Photoparoxysmal Response

Phase: N/A Priority: Normal

NCT ID: NCT02351115 Org: User:

Start: 01/31/15 End: 07/31/16 Due: 07/31/17

Staccato Loxapine Pulmonary Safety in Patients With Asthma

Phase: N/A Priority: Normal

NCT ID: NCT00890175 Org: User:

Start: 05/31/09 End: 08/31/09 Due: 08/31/10

Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT04157933 Org: User:

Start: 10/16/19 End: 03/06/20 Due: 03/06/21

Staccato Loxapine Single Dose PK

Phase: N/A Priority: Normal

NCT ID: NCT00444028 Org: User:

Start: 09/30/05 End: 11/30/05 Due: 11/30/06

Staccato Fentanyl Single and Multidose PK

Phase: N/A Priority: Normal

NCT ID: NCT00402350 Org: User:

Start: 04/30/06 End: 11/30/06 Due: 11/30/07

Staccato Loxapine in Agitated Patients With Bipolar Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00721955 Org: User:

Start: 07/31/08 End: 10/31/08 Due: 10/31/09

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Phase: N/A Priority: Normal

NCT ID: NCT05979415 Org: User:

Start: 09/27/23 End: 02/28/24 Due: 02/28/25

Staccato Apomorphine Single and Multi Dose PK

Phase: N/A Priority: Normal

NCT ID: NCT03822364 Org: User:

Start: 11/26/18 End: 03/26/19 Due: 03/26/20

Staccato Prochlorperazine in Migraine (in Clinic)

Phase: N/A Priority: Normal

NCT ID: NCT00610428 Org: User:

Start: 03/31/05 End: 10/31/05 Due: 10/31/06

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome	NCT04645953	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2021-02-05	2022-07-26	2023-07-26	-	-	2025-07-14
Staccato Loxapine Multidose PK	NCT00555412	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2007-10-31	2007-12-31	2008-12-31	-	-	2025-07-14
Staccato Loxapine in Agitated Patients With Schizophrenia	NCT00628589	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2008-02-29	2008-05-31	2009-05-31	-	-	2025-07-14
Staccato Prochlorperazine in Migraine (Out Patient)	NCT00422812	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2006-04-30	2007-01-31	2008-01-31	-	-	2025-07-14
Staccato Alprazolam in Panic Attack	NCT00477451	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2007-05-31	2008-04-30	2009-04-30	-	-	2025-07-14
Staccato Loxapine Pulmonary Safety in Healthy Volunteers	NCT00789360	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2008-11-30	2009-04-30	2010-04-30	-	-	2025-07-14
Staccato Zaleplon Single Dose Pharmacokinetics	NCT00620620	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2008-02-29	2008-03-31	2009-03-31	-	-	2025-07-14
ADASUVE-Lorazepam Drug-Drug Interaction	NCT01877642	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2013-06-30	2013-07-31	2014-07-31	-	-	2025-07-14
Staccato Prochlorperazine Single Dose PK Study	NCT00610727	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2004-08-31	2004-10-31	2005-10-31	-	-	2025-07-14
Staccato Loxapine PK in Smokers and Nonsmokers	NCT00873769	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2009-04-30	2009-06-30	2010-06-30	-	-	2025-07-14
Staccato Loxapine in Migraine (in Clinic)	NCT00489476	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2007-06-30	2007-12-31	2008-12-31	-	-	2025-07-14
Staccato Loxapine Thorough QT/QTc Study	NCT00874237	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2009-04-30	2009-06-30	2010-06-30	-	-	2025-07-14
Staccato Alprazolam Abuse Liability	NCT00603980	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2008-01-31	2009-01-31	2010-01-31	-	-	2025-07-14
ADASUVE 2-dose Thorough QT/QTc Study	NCT01854710	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2013-05-31	2013-07-31	2014-07-31	-	-	2025-07-14
Staccato Loxapine Pulmonary Safety in Patients With COPD	NCT00889837	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2009-06-30	2009-08-31	2010-08-31	-	-	2025-07-14
Staccato Prochlorperazine Thorough QT/QTc	NCT00543062	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2007-10-31	2007-12-31	2008-12-31	-	-	2025-07-14
Staccato Alprazolam and Photoparoxysmal Response	NCT02351115	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2015-01-31	2016-07-31	2017-07-31	-	-	2025-07-14
Staccato Loxapine Pulmonary Safety in Patients With Asthma	NCT00890175	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2009-05-31	2009-08-31	2010-08-31	-	-	2025-07-14
Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease	NCT04157933	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2019-10-16	2020-03-06	2021-03-06	-	-	2025-07-14
Staccato Loxapine Single Dose PK	NCT00444028	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2005-09-30	2005-11-30	2006-11-30	-	-	2025-07-14
Staccato Fentanyl Single and Multidose PK	NCT00402350	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2006-04-30	2006-11-30	2007-11-30	-	-	2025-07-14
Staccato Loxapine in Agitated Patients With Bipolar Disorder	NCT00721955	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2008-07-31	2008-10-31	2009-10-31	-	-	2025-07-14
Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes	NCT05979415	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2023-09-27	2024-02-28	2025-02-28	-	-	2025-07-14
Staccato Apomorphine Single and Multi Dose PK	NCT03822364	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2018-11-26	2019-03-26	2020-03-26	-	-	2025-07-14
Staccato Prochlorperazine in Migraine (in Clinic)	NCT00610428	Alexza Pharmaceuticals, Inc.	user2@example.com	None	2005-03-31	2005-10-31	2006-10-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance